Trial participants need to be more representative of patientsBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39539.578507.DB (Published 03 April 2008) Cite this as: BMJ 2008;336:737
- Bob Roehr
- 1Washington, DC
A new report is calling for changes in the conduct of clinical trials in the United States to reduce disparities of age, sex, race, and comorbidity. The goal is to give a more representative picture of the benefits and risks of a treatment across the entire population but particularly among those who bear the greatest burden of the morbidity.
The eliminating disparities in clinical trials (EDICT) initiative was conducted over two years by the Baylor College of Medicine in Houston and the Intercultural Cancer Council. It is part of an ongoing four year project to reduce barriers to participation in trials. The report of the initiative was released on 1 …
Log in using your username and password
Log in through your institution
Sign up for a free trial